BGB-58067
2025-24
Phase 1 small_molecule active
Quick answer
BGB-58067 for Glioblastoma (GBM) is a Phase 1 program (small_molecule) at BEONE MEDICINES AUS PTY LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BEONE MEDICINES AUS PTY LTD
- Indication
- Glioblastoma (GBM)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active